NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

RWE(真實世界證據Real-World Evidence)解決方案的全球市場分析(2020-2030年):按組件,數據集,治療區域,最終用戶,地區,新型冠狀病毒感染(COVID-19)進行的預測主要公司簡介的恢復方案

Real-World Evidence (RWE) Solutions Market Report 2020-2030: Forecasts by Component, Datasets, Therapeutic Area, End-users, by Region, COVID-19 Recovery Scenarios, Profiles of Leading Companies

出版商 Visiongain Ltd 商品編碼 977380
出版日期 內容資訊 英文 277 Pages
商品交期: 最快1-2個工作天內
價格
RWE(真實世界證據Real-World Evidence)解決方案的全球市場分析(2020-2030年):按組件,數據集,治療區域,最終用戶,地區,新型冠狀病毒感染(COVID-19)進行的預測主要公司簡介的恢復方案 Real-World Evidence (RWE) Solutions Market Report 2020-2030: Forecasts by Component, Datasets, Therapeutic Area, End-users, by Region, COVID-19 Recovery Scenarios, Profiles of Leading Companies
出版日期: 2020年10月01日內容資訊: 英文 277 Pages
簡介

本報告分析了真實世界證據Real-World Evidence(RWE)解決方案的市場,並提供了產品概述,市場的基本結構/最新情況,主要推動者/限制因素以及市場規模的估計/預測(未來11年),未來的市場復甦方案,按組件/數據集/最終用戶/治療區域和地區/主要國家/地區劃分的詳細趨勢,主要公司的概況,COVID-19的影響方案,我們將收集和傳遞諸如此類的信息。

目錄

第1章分析概述

第2章執行摘要

第3章行業考慮

  • 促進因素
    • 在醫療行業中對大數據的更多使用
    • 越來越多地使用智能可穿戴傳感器設備進行RWE數據收集
    • RWE在生物製藥中的用途
    • 使用RWE加強臨床試驗
  • 抑制因素
    • 患者隱私問題
    • 缺乏適當的融資和大量的資本投資
  • 市場機會
    • 傳播以患者為中心的計劃
    • 慢性病管理的長期前景
  • SWOT分析
  • 行業分析:波特的五力分析
    • 買方的議價能力(低)
    • 供應商的議價能力(高)
    • 公司之間的競爭狀況(中)
    • 替代產品威脅(低)
    • 新進入者的威脅(高)

第4章RWE解決方案市場:按組件

  • 市場收入及其預測,增長率(金額基準,2020-2030年):COVID-19或更早/恢復情況
  • 數據收集(數據集)
  • 服務(藥物作用,藥物使用等)

第5章RWE解決方案市場:按數據集

  • 市場收入/增長率及其預測(金額基準,2020-2030年):COVID-19或更早版本/恢復情況
  • 臨床環境數據
  • 帳單數據
  • 藥房數據
  • 患者數據

第6章RWE解決方案市場:按處理區域

  • 市場收入/增長率及其預測(金額基準,2020-2030年):COVID-19或更早版本/恢復情況
  • 腫瘤
  • 心血管疾病(CVD)
  • 神經症
  • 免疫疾病
  • 其他

第7章RWE解決方案市場:按最終用戶

  • 市場收入/增長率及其預測(金額基準,2020-2030年):COVID-19或更早版本/恢復情況
  • 付款人
  • 醫療提供者(提供者)
  • 製藥公司/醫療設備製造商
  • 其他

第8章RWE解決方案市場:按地區/國家(2020-2030)

  • 各地區的趨勢預測(2020-2030)
  • 區域恢復方案

第9章北美

  • 市場概況:慢性病患者數量增加
  • 北美RWE解決方案市場:國家預測(2020-2030)
  • 市場預測:按組成部分(2020-2030)
  • 市場預測:按數據集(2020-2030)
  • 市場預測:按治療區域分(2020-2030)
  • 市場預測:按最終用戶劃分(2020-2030)
  • 美國市場
  • 加拿大市場
    • 市場概況
    • 市場復甦情景(V形/U形/W形/L形恢復)(2020-2030)

第10章歐洲

  • 市場概述:使用RWE進行藥品快速認證
  • 歐洲RWE解決方案市場:國家預測(2020-2030)
  • 市場預測:按組成部分(2020-2030)
  • 市場預測:按數據集(2020-2030)
  • 市場預測:按治療區域分(2020-2030)
  • 市場預測:按最終用戶劃分(2020-2030)
  • 德國市場
  • 法國市場
  • 英國市場
  • 意大利市場
  • 西班牙市場
  • 其他歐洲國家的市場

第11章亞太

  • 市場概況:市場快速增長
  • 歐洲RWE解決方案市場:國家預測(2020-2030)
  • 市場預測:按組成部分(2020-2030)
  • 市場預測:按數據集(2020-2030)
  • 市場預測:按治療區域分(2020-2030)
  • 市場預測:按最終用戶劃分(2020-2030)
  • 日本市場
  • 中國市場
  • 印度市場
  • 亞太其他國家/地區的市場

第12章其他國家(RoW)

  • 市場預測:按組成部分(2020-2030)
  • 市場預測:按數據集(2020-2030)
  • 市場預測:按治療區域分(2020-2030)
  • 市場預測:按最終用戶劃分(2020-2030)
  • 市場預測(2020-2030)
    • 市場復甦情景(V形/U形/W形/L形恢復)(2020-2030)

第13章代表公司

  • Iqvia
  • IBM
  • Pharmaceutical Product Development (PPD)
  • PAREXEL
  • Optum (Subsidiary of United Health Group, Inc.)
  • PerkinElmer Inc.
  • Icon PLC
  • Anthem
  • Oracle
  • Cognizant
  • Syneos Health
  • Clinigen
  • Covance Inc.

第14章結論/建議

目錄
Product Code: PHA0928

Title:
Real-World Evidence (RWE) Solutions Market Report 2020-2030
Forecasts by Component (Data Sets, Services), Datasets (Clinical Settings Data, Claims Data, Pharmacy Data, Patient-Powered Data, Others), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurology, Immunology, Other Therapeutic Areas), End-users (Healthcare Payers, Healthcare Providers, Pharmaceutical & Medical Device Companies, Other End-users), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), PLUS COVID-19 Recovery Scenarios and Profiles of Leading Real-World Evidence Solutions Companies.

Real-world evidence (RWE) will be essential in beating COVID-19. Patients, vaccine recipients, healthcare workers - Real-World data needs to be gathered to guide treatment decisions, risk-assessments, and standards of care and practice.

RWE is essential NOW. You must read this report - today. RWE offers you a treatment roadmap - read this report to discover how.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report immediately.

Drivers

  • Increasing us of big Data in Healthcare
  • Growing use of smart wearables, sensors, and devices which collect real world data
  • Usage of RWE in biopharma
  • RWE can enhance clinical trials as seen in COVID-19 work

Restraints

  • Patient privacy issue
  • Lack of adequate financing and high capital investment

Opportunities

  • Increasing use of patient centric programs
  • Long term outlook for chronic disease management

This report tells you how to stay ahead

  • Unique 270+ page report - delivers 350+ tables and charts/graphs.
  • Find out the most lucrative areas in the industry and the future market prospects.
  • Delivers forecasted sales at overall world market, regional and country level.
  • Gives you financial results, trends, opportunities, and revenue predictions.
  • Shows you the opportunities in this growing Real-World Evidence Market and how to exploit them.

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, product profiles and commercial developments.

UNIQUE COVID-19 VARIATIONS - only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop - no matter how COVID-19 effects the economy.

Discover sales predictions for the world market and submarkets

By Component

  • Data Sets
  • Services

By Datasets

  • Clinical Settings Data
  • Claims Data
  • Pharmacy Data
  • Patient-Powered Data
  • Others

By Therapeutic Area

  • Oncology
  • Cardiovascular Diseases
  • Neurology
  • Immunology
  • Other Therapeutic Areas

By End-Users

  • Healthcare Payers
  • Healthcare Providers
  • Pharmaceutical & Medical Device Companies
  • Other End-Users

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, product profiles and commercial developments.

UNIQUE COVID-19 VARIATIONS - only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop - no matter how COVID-19 effects the economy.

Discover sales predictions for the world market and submarkets

By Component

  • Data Sets
  • Services

By Datasets

  • Clinical Settings Data
  • Claims Data
  • Pharmacy Data
  • Patient-Powered Data
  • Others

By Therapeutic Area

  • Oncology
  • Cardiovascular Diseases
  • Neurology
  • Immunology
  • Other Therapeutic Areas

By End-Users

  • Healthcare Payers
  • Healthcare Providers
  • Pharmaceutical & Medical Device Companies
  • Other End-Users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 10 leading national markets:

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • RoW

Leading companies and the potential for market growth

Overall world revenue for Real-World Evidence Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Real-World Evidence Market report helps you

In summary, our 270+ page report provides you with the following knowledge:

  • Revenue forecasts to 2030 for Real-World Evidence Market, with forecasts for xx, each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2030 for 5 regional and xx key national markets - See forecasts for the Real-World Evidence market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, and Japan, among other prominent economies.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 13 of the major companies involved in the Real-World Evidence Market. Some of the company's profiled in this report include:
  • Iqvia
  • IBM
  • Pharmaceutical Product Development
  • PAREXEL
  • Optum (A Subsidiary of United Health Group, Inc.)
  • PerkinElmer
  • Icon PLC
  • Oracle
  • Cognizant
  • Syneos Health
  • Anthem
  • Clinigen
  • Covance Inc.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Real-World Evidence Market and leading companies. You will find data, trends and predictions.

Buy our report today Real-World Evidence (RWE) Solutions Market Report 2020-2030: Forecasts by Component (Data Sets, Services), Datasets (Clinical Settings Data, Claims Data, Pharmacy Data, Patient-Powered Data, Others), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurology, Immunology, Other Therapeutic Areas), End-users (Healthcare Payers, Healthcare Providers, Pharmaceutical & Medical Device Companies, Other End-users), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), PLUS COVID-19 Recovery Scenarios and Profiles of Leading Real-World Evidence Solutions Companies. Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Introduction to Real-World Evidence Solutions Market
  • 1.2 Real-World Evidence Solutions Market Definition
  • 1.3 Why You Should Read This Report
  • 1.4 What This Report Delivers
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 COVID-19 Impact: Recovery Scenarios
    • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

  • 2.1 Market Outlook

3 Industry Insights

  • 3.1 Drivers
    • 3.1.1 Increasing use of Bigdata in Healthcare Industry
    • 3.1.2 Growing use of smart wearables, sensors, and devices which collect real world data
    • 3.1.3 Usage of RWE in Biopharma
    • 3.1.4 RWE Can Enhance Clinical Trials
  • 3.2 Restraints
    • 3.2.1 Patient Privacy Issues
    • 3.2.2 Lack of adequate financing and high capital investments
  • 3.3 Opportunities
    • 3.3.1 Increasing adoption of Patient-Centric Programs
    • 3.3.2 Long-Term Outlook for Chronic Disease Management
  • 3.4 SWOT Analysis
    • 3.4.1 Strengths
    • 3.4.2 Weaknesses
    • 3.4.3 Opportunities
    • 3.4.4 Threats
  • 3.5 Industry analysis - Porter's
    • 3.5.1 Bargaining Power of Buyer to Have Low Impact
    • 3.5.2 Bargaining Power of Supplier to Have High Impact
    • 3.5.3 Competitive Rivalry is Medium
    • 3.5.4 Threat of Substitutes if Low
    • 3.5.5 High Threat from New Entrants

4 Real-World Evidence Solutions Market by Component

  • 4.1 Revenue and Forecasts, 2020-2030 (US$ Mn, AGR%, CAGR%) (Pre-COVID & Recovery Scenarios)
  • 4.2 Data Gathering in Healthcare is Growing at Exponential Rates
  • 4.3 Services Such as Drug Effects & Drug Utilization to Offer Lucrative Growth Opportunities

5 Real-World Evidence Solutions Market by Datasets

  • 5.1 Revenue and Forecasts, 2020-2030 (US$ Mn, AGR%, CAGR%) (Pre-COVID & Recovery Scenarios)
  • 5.2 Clinical Settings Data offers Organizations with Efficient Clinical Care
  • 5.3 Claims Data to Strengthen RWE Market
  • 5.4 Pharmacy Data to Garner Huge Demand from Pharmaceutical Companies
  • 5.5 Patient-Powered Data Which Fosters Data Sharing Partnership to Fuel Market Growth

6 Real-World Evidence Solutions Market by Therapeutic Area

  • 6.1 Revenue and Forecasts, 2020-2030 (US$ Mn, AGR%, CAGR%) (Pre-COVID & Recovery Scenarios)
  • 6.2 Oncology Segment to Garner Maximum Market Share
  • 6.3 Cardiovascular Diseases: Usage of RWE to Offer Better Safety & Effectiveness in CVDs Drugs
  • 6.4 Neurology: Role of RWE in Neurology Research
  • 6.5 Immunology Segment to Witness Lucrative Growth
  • 6.6 Other Therapeutic Areas

7 Real-World Evidence Solutions Market by End-Users

  • 7.1 Revenue and Forecasts, 2020-2030 (US$ Mn, AGR%, CAGR%) (Pre-COVID & Recovery Scenarios)
  • 7.2 Healthcare Payers: Rising Need of Privacy and Security Concerns
  • 7.3 Healthcare Providers: Growing Usage of EHR to Support Market Growth
  • 7.4 Pharmaceutical & Medical Device Companies to Witness Highest Growth Rate Owing to Growing Demand for Accelerated Drug Approval Process
  • 7.5 Other End-Users

8 Regional and Leading National Real-World Evidence Solutions Market Forecasts 2020-2030

  • 8.1 Global Real-World Evidence Solutions Market by Region Forecast 2020-2030
  • 8.2 Recovery Scenarios by Region

9 North America

  • 9.1 Increasing Prevalence of Chronic Diseases
  • 9.2 North America Real-World Evidence Solutions Market by Country Forecast 2020-2030
  • 9.3 North America Real-World Evidence Solutions Market Forecast by Component
    • 9.3.1 Data Sets Segment Revenue and Forecast, 2020-2030
    • 9.3.2 Services Segment Revenue and Forecast, 2020-2030
  • 9.4 North America Real-World Evidence Solutions Market Forecast by Datasets
    • 9.4.1 Clinical Settings Data Segment Revenue and Forecast, 2020-2030
    • 9.4.2 Claims Data Segment Revenue and Forecast, 2020-2030
    • 9.4.3 Pharmacy Data Segment Revenue and Forecast, 2020-2030
    • 9.4.4 Patient-Powered Data Segment Revenue and Forecast, 2020-2030
  • 9.5 North America Real-World Evidence Solutions Market Forecast by Therapeutic Area
    • 9.5.1 Oncology Segment Revenue and Forecast, 2020-2030
    • 9.5.2 CVDs Segment Revenue and Forecast, 2020-2030
    • 9.5.3 Neurology Segment Revenue and Forecast, 2020-2030
    • 9.5.4 Immunology Segment Revenue and Forecast, 2020-2030
    • 9.5.5 Other Therapeutic Areas Revenue and Forecast, 2020-2030
  • 9.6 North America Real-World Evidence Solutions Market Forecast by End-Users
    • 9.6.1 Healthcare Payers Segment Revenue and Forecast, 2020-2030
    • 9.6.2 Healthcare Providers Segment Revenue and Forecast, 2020-2030
    • 9.6.3 Pharma & Medical Device Segment Revenue and Forecast, 2020-2030
    • 9.6.4 Other End Users Revenue and Forecast, 2020-2030
  • 9.7 U.S. Real-World Evidence Solutions Market Forecast 2020-2030
    • 9.7.1 U.S. Has one of the Advanced Healthcare System in the World
    • 9.7.2 Recovery Scenarios (V, U, W, L): U.S. Real-World Evidence Solutions Market Forecast, 2020-2030
  • 9.8 Canada Real-World Evidence Solutions Market Forecast 2020-2030
    • 9.8.1 Canada is Developing Essential Infrastructure to Collect Real-World Insights
    • 9.8.2 Recovery Scenarios (V, U, W, L): Canada Real-World Evidence Solutions Market Forecast, 2020-2030

10 Europe

  • 10.1 RWE in Europe is Being Used for Fast-Tracked Access to Drugs
  • 10.2 Europe Real-World Evidence Solutions Market by Country Forecast 2020-2030
  • 10.3 Europe Real-World Evidence Solutions Market Forecast by Component
    • 10.3.1 Data Sets Segment Revenue and Forecast, 2020-2030
    • 10.3.2 Services Segment Revenue and Forecast, 2020-2030
  • 10.4 Europe Real-World Evidence Solutions Market Forecast by Datasets
    • 10.4.1 Clinical Settings Data Segment Revenue and Forecast, 2020-2030
    • 10.4.2 Claims Data Segment Revenue and Forecast, 2020-2030
    • 10.4.3 Pharmacy Data Segment Revenue and Forecast, 2020-2030
    • 10.4.4 Patient Powered Data Segment Revenue and Forecast, 2020-2030
  • 10.5 Europe Real-World Evidence Solutions Market Forecast by Therapeutic Area
    • 10.5.1 Oncology Segment Revenue and Forecast, 2020-2030
    • 10.5.2 CVDs Segment Revenue and Forecast, 2020-2030
    • 10.5.3 Neurology Segment Revenue and Forecast, 2020-2030
    • 10.5.4 Immunology Segment Revenue and Forecast, 2020-2030
    • 10.5.5 Other Therapeutic Areas Revenue and Forecast, 2020-2030
  • 10.6 Europe Real-World Evidence Solutions Market Forecast by End-Users
    • 10.6.1 Healthcare Payers Segment Revenue and Forecast, 2020-2030
    • 10.6.2 Healthcare Providers Segment Revenue and Forecast, 2020-2030
    • 10.6.3 Pharma & Medical Device Segment Revenue and Forecast, 2020-2030
    • 10.6.4 Other End Users Revenue and Forecast, 2020-2030
  • 10.7 Germany Real-World Evidence Solutions Market Forecast 2020-2030
    • 10.7.1 Growing Acceptance of RWE
    • 10.7.2 Recovery Scenarios (V, U, W, L): Germany Real-World Evidence Solutions Market Forecast, 2020-2030
  • 10.8 France Real-World Evidence Solutions Market Forecast 2020-2030
    • 10.8.1 Introduction
    • 10.8.2 Recovery Scenarios (V, U, W, L): France Real-World Evidence Solutions Market Forecast, 2020-2030
  • 10.9 UK Real-World Evidence Solutions Market Forecast 2020-2030
    • 10.9.1 UK Plays an Important Role in Real World Data Capacity
    • 10.9.2 Recovery Scenarios (V, U, W, L): UK Real-World Evidence Solutions Market Forecast, 2020-2030
  • 10.10 Italy Real-World Evidence Solutions Market Forecast 2020-2030
    • 10.10.1 Huge Market Potential
    • 10.10.2 Recovery Scenarios (V, U, W, L): Italy Real-World Evidence Solutions Market Forecast, 2020-2030
  • 10.11 Spain Real-World Evidence Solutions Market Forecast 2020-2030
    • 10.11.1 RWE Solutions to Reform Healthcare System in Spain
    • 10.11.2 Recovery Scenarios (V, U, W, L): Spain Real-World Evidence Solutions Market Forecast, 2020-2030
  • 10.12 Rest of Europe Real-World Evidence Solutions Market Forecast 2020-2030
    • 10.12.1 Significant Growth Opportunities for RWE Players Across the Region
    • 10.12.2 Recovery Scenarios (V, U, W, L): Rest of Europe Real-World Evidence Solutions Market Forecast, 2020-2030

11 Asia Pacific

  • 11.1 Asia Pacific RWE Market to Witness Highest Growth Rate
  • 11.2 Asia Pacific Real-World Evidence Solutions Market by Country Forecast 2020-2030
  • 11.3 Asia Pacific Real-World Evidence Solutions Market Forecast by Component
    • 11.3.1 Data Sets Segment Revenue and Forecast, 2020-2030
    • 11.3.2 Services Segment Revenue and Forecast, 2020-2030
  • 11.4 Asia Pacific Real-World Evidence Solutions Market Forecast by Datasets
    • 11.4.1 Clinical Settings Data Segment Revenue and Forecast, 2020-2030
    • 11.4.2 Claims Data Segment Revenue and Forecast, 2020-2030
    • 11.4.3 Pharmacy Data Segment Revenue and Forecast, 2020-2030
    • 11.4.4 Patient Powered Data Segment Revenue and Forecast, 2020-2030
  • 11.5 Asia Pacific Real-World Evidence Solutions Market Forecast by Therapeutic Area
    • 11.5.1 Oncology Segment Revenue and Forecast, 2020-2030
    • 11.5.2 CVDs Segment Revenue and Forecast, 2020-2030
    • 11.5.3 Neurology Segment Revenue and Forecast, 2020-2030
    • 11.5.4 Immunology Segment Revenue and Forecast, 2020-2030
    • 11.5.5 Other Therapeutic Areas Revenue and Forecast, 2020-2030
  • 11.6 Asia Pacific Real-World Evidence Solutions Market Forecast by End-Users
    • 11.6.1 Healthcare Payers Segment Revenue and Forecast, 2020-2030
    • 11.6.2 Healthcare Providers Segment Revenue and Forecast, 2020-2030
    • 11.6.3 Pharma & Medical Device Segment Revenue and Forecast, 2020-2030
    • 11.6.4 Other End Users Revenue and Forecast, 2020-2030
  • 11.7 Japan Real-World Evidence Solutions Market Forecast 2020-2030
    • 11.7.1 Japan is One of The Leading Countries to Adopt RWE Solutions
    • 11.7.2 Recovery Scenarios (V, U, W, L): Japan Real-World Evidence Solutions Market Forecast, 2020-2030
  • 11.8 China Real-World Evidence Solutions Market Forecast 2020-2030
    • 11.8.1 China Projected to Witness Substantial Challenges
    • 11.8.2 Recovery Scenarios (V, U, W, L): China Real-World Evidence Solutions Market Forecast, 2020-2030
  • 11.9 India Real-World Evidence Solutions Market Forecast 2020-2030
    • 11.9.1 India is Facing a lot of Difficulty in Implementing RWE Due to Lack of Data Collection Platform and Sources
    • 11.9.2 Recovery Scenarios (V, U, W, L): India Real-World Evidence Solutions Market Forecast, 2020-2030
  • 11.10 Rest of Asia Pacific Real-World Evidence Solutions Market Forecast 2020-2030
    • 11.10.1 Introduction
    • 11.10.2 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Real-World Evidence Solutions Market Forecast, 2020-2030

12 Rest of the World

  • 12.1 RoW Real-World Evidence Solutions Market Forecast by Component
    • 12.3.1 Data Sets Segment Revenue and Forecast, 2020-2030
    • 12.3.2 Services Segment Revenue and Forecast, 2020-2030
  • 12.2 RoW Real-World Evidence Solutions Market Forecast by Datasets
    • 12.2.1 Clinical Settings Data Segment Revenue and Forecast, 2020-2030
    • 12.2.2 Claims Data Segment Revenue and Forecast, 2020-2030
    • 12.2.3 Pharmacy Data Segment Revenue and Forecast, 2020-2030
    • 12.2.4 Patient Powered Data Segment Revenue and Forecast, 2020-2030
  • 12.3 RoW Real-World Evidence Solutions Market Forecast by Therapeutic Area
    • 12.3.1 Oncology Segment Revenue and Forecast, 2020-2030
    • 12.3.2 CVDs Segment Revenue and Forecast, 2020-2030
    • 12.3.3 Neurology Segment Revenue and Forecast, 2020-2030
    • 12.3.4 Immunology Segment Revenue and Forecast, 2020-2030
    • 12.3.5 Other Therapeutic Areas Revenue and Forecast, 2020-2030
  • 12.4 RoW Real-World Evidence Solutions Market Forecast by End-Users
    • 12.4.1 Healthcare Payers Segment Revenue and Forecast, 2020-2030
    • 12.4.2 Healthcare Providers Segment Revenue and Forecast, 2020-2030
    • 12.4.3 Pharma & Medical Device Segment Revenue and Forecast, 2020-2030
    • 12.4.4 Other End Users Revenue and Forecast, 2020-2030
  • 12.5 RoW Real-World Evidence Solutions Market Forecast 2020-2030
    • 12.5.1 Recovery Scenarios (V, U, W, L): RoW Real-World Evidence Solutions Market Forecast, 2020-2030

13 Leading Companies

  • 13.1 Iqvia
    • 13.1.1 Company Snapshot, 2020
    • 13.1.2 Company Overview
    • 13.1.3 Financial Analysis, 2015-2019
    • 13.1.4 Products
    • 13.1.5 Recent Developments, 2018-2019
  • 13.2 IBM
    • 13.2.1 Company Snapshot, 2020
    • 13.2.2 Company Overview
    • 13.2.3 Financial Analysis, 2015-2019
    • 13.2.4 Products
    • 13.2.5 Recent Developments, 2020
  • 13.3 Pharmaceutical Product Development (PPD)
    • 13.3.1 Company Snapshot, 2020
    • 13.3.2 Company Overview
    • 13.3.3 Products
  • 13.4 PAREXEL
    • 13.4.1 Company Snapshot, 2020
    • 13.4.2 Company Overview
    • 13.4.3 Products
    • 13.4.4 Recent Developments, 2020
  • 13.5 Optum (Subsidiary of United Health Group, Inc.)
    • 13.5.1 Company Snapshot, 2020
    • 13.5.2 Company Overview
    • 13.5.3 Financial Analysis, 2015-2019
    • 13.5.4 Products
    • 13.5.5 Recent Developments, 2020
  • 13.6 PerkinElmer Inc.
    • 13.6.1 Company Snapshot, 2020
    • 13.6.2 Company Overview
    • 13.6.3 Financial Analysis, 2015-2019
    • 13.6.4 Products
  • 13.7 Icon PLC
    • 13.7.1 Company Snapshot, 2020
    • 13.7.2 Company Overview
    • 13.7.3 Financial Analysis, 2015-2019
    • 13.7.4 Products
  • 13.8 Anthem
    • 13.8.1 Company Snapshot, 2020
    • 13.8.2 Company Overview
    • 13.8.3 Financial Analysis, 2015-2019
    • 13.8.4 Products
  • 13.9 Oracle
    • 13.9.1 Company Snapshot, 2020
    • 13.9.2 Company Overview
    • 13.9.3 Financial Analysis, 2015-2019
    • 13.9.4 Products
    • 13.9.5 Recent Developments, 2019
  • 13.10 Cognizant
    • 13.10.1 Company Snapshot, 2020
    • 13.10.2 Company Overview
    • 13.10.3 Financial Analysis, 2015-2019
    • 13.10.4 Recent Developments, 2019
  • 13.11 Syneos Health
    • 13.11.1 Company Snapshot, 2020
    • 13.11.2 Company Overview
    • 13.11.3 Financial Analysis, 2015-2019
    • 13.11.4 Products
    • 13.11.5 Recent Developments, 2018-2020
  • 13.12 Clinigen
    • 13.12.1 Company Snapshot, 2020
    • 13.12.2 Company Overview
    • 13.12.3 Financial Analysis, 2015-2019
    • 13.12.4 Products
  • 13.13 Covance Inc.
    • 13.13.1 Company Snapshot, 2020
    • 13.13.2 Company Overview
    • 13.13.3 Financial Analysis, 2015-2019
    • 13.13.4 Products
    • 13.13.5 Recent Developments, 2018-2019

14 Conclusion and Recommendations

  • 14.1 Concluding Remarks
  • 14.2 Recommendations

List of Tables

  • Table 1 Global Real-World Evidence Solutions Market Snapshot, 2020 & 2030 (US$ million, CAGR %)
  • Table 2 Global Real-World Evidence Market by Component Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 3 Global Real-World Evidence Market Forecast for Datasets, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 4 Global Real-World Evidence Market Forecast for Datasets, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 5 Global Real-World Evidence Market Forecast for Datasets, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 6 Global Real-World Evidence Market Forecast for Datasets, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 7 Global Real-World Evidence Market Forecast for Datasets, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 8 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 9 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 10 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 11 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 12 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 13 Global Real-World Evidence Market by Datasets Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 14 Global Real-World Evidence Market Forecast for Clinical Settings Data, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 15 Global Real-World Evidence Market Forecast for Clinical Settings Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 16 Global Real-World Evidence Market Forecast for Clinical Settings Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 17 Global Real-World Evidence Market Forecast for Clinical Settings Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 18 Global Real-World Evidence Market Forecast for Clinical Settings Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 19 Global Real-World Evidence Market Forecast for Claims Data, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 20 Global Real-World Evidence Market Forecast for Claims Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 21 Global Real-World Evidence Market Forecast for Claims Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 22 Global Real-World Evidence Market Forecast for Claims Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 23 Global Real-World Evidence Market Forecast for Claims Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 24 Global Real-World Evidence Market Forecast for Pharmacy Data, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 25 Global Real-World Evidence Market Forecast for Pharmacy Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 26 Global Real-World Evidence Market Forecast for Pharmacy Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 27 Global Real-World Evidence Market Forecast for Pharmacy Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 28 Global Real-World Evidence Market Forecast for Pharmacy Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 29 Global Real-World Evidence Market Forecast for Patient-Powered Data, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 30 Global Real-World Evidence Market Forecast for Patient-Powered Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 31 Global Real-World Evidence Market Forecast for Patient-Powered Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 32 Global Real-World Evidence Market Forecast for Patient-Powered Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 33 Global Real-World Evidence Market Forecast for Patient-Powered Data, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 34 Global Real-World Evidence Market by Formulation Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 35 Global Real-World Evidence Market Forecast for Oncology, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 36 Global Real-World Evidence Market Forecast for Oncology, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 37 Global Real-World Evidence Market Forecast for Oncology, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 38 Global Real-World Evidence Market Forecast for Oncology, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 39 Global Real-World Evidence Market Forecast for Oncology, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 40 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 41 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 42 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 43 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 44 Global Real-World Evidence Market Forecast for Services, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 45 Global Real-World Evidence Market Forecast for Neurology, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 46 Global Real-World Evidence Market Forecast for Neurology, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 47 Global Real-World Evidence Market Forecast for Neurology, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 48 Global Real-World Evidence Market Forecast for Neurology, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 49 Global Real-World Evidence Market Forecast for Neurology, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 50 Global Real-World Evidence Market Forecast for Immunology, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 51 Global Real-World Evidence Market Forecast for Immunology, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 52 Global Real-World Evidence Market Forecast for Immunology, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 53 Global Real-World Evidence Market Forecast for Immunology, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 54 Global Real-World Evidence Market Forecast for Immunology, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 55 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 56 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 57 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 58 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 59 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 60 Global Real-World Evidence Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 61 Global Real-World Evidence Market Forecast for Healthcare Payers, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 62 Global Real-World Evidence Market Forecast for Healthcare Payers, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 63 Global Real-World Evidence Market Forecast for Healthcare Payers, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 64 Global Real-World Evidence Market Forecast for Healthcare Payers, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 65 Global Real-World Evidence Market Forecast for Healthcare Payers, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 66 Global Real-World Evidence Market Forecast for Healthcare Providers, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 67 Global Real-World Evidence Market Forecast for Healthcare Providers, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 68 Global Real-World Evidence Market Forecast for Healthcare Providers, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 69 Global Real-World Evidence Market Forecast for Healthcare Providers, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 70 Global Real-World Evidence Market Forecast for Healthcare Providers, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 71 Global Real-World Evidence Market Forecast for Pharma & Medical Device Companies, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 72 Global Real-World Evidence Market Forecast for Pharma & Medical Device Companies, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 73 Global Real-World Evidence Market Forecast for Pharma & Medical Device Companies, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 74 Global Real-World Evidence Market Forecast for Pharma & Medical Device Companies, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 75 Global Real-World Evidence Market Forecast for Pharma & Medical Device Companies, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 76 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 77 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 78 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 79 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 80 Global Real-World Evidence Market Forecast for Others, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 81 Global Real-World Evidence Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 82 Global Real-World Evidence Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 83 Global Real-World Evidence Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%); "U" Shaped Recovery
  • Table 84 Global Real-World Evidence Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 85 Global Real-World Evidence Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 86 North America Real-World Evidence Market by Country Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 87 North America Real-World Evidence Market by Component Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 88 North America Real-World Evidence Market by Datasets Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 89 North America Real-World Evidence Market by Therapeutic Area Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 90 North America Real-World Evidence Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 91 U.S. Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 92 U.S. Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 93 U.S. Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 94 U.S. Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 95 U.S. Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 96 Canada Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 97 Canada Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 98 Canada Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 99 Canada Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 100 Canada Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 101 Europe Real-World Evidence Market by Country Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 102 Europe Real-World Evidence Market by Component Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 103 Europe Real-World Evidence Market by Datasets Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 104 Europe Real-World Evidence Market by Therapeutic Area Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 105 Europe Real-World Evidence Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 106 Germany Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 107 Germany Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 108 Germany Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 109 Germany Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 110 Germany Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 111 France Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 112 France Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 113 France Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 114 France Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 115 France Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 116 UK Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 117 UK Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 118 UK Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 119 UK Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 120 UK Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 121 Italy Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 122 Italy Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 123 Italy Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 124 Italy Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 125 Italy Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 126 Spain Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 127 Spain Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 128 Spain Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 129 Spain Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 130 Spain Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 131 Rest of Europe Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 132 Rest of Europe Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 133 Rest of Europe Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 134 Rest of Europe Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 135 Rest of Europe Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 136 Asia Pacific Real-World Evidence Market by Country Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 137 Asia Pacific Real-World Evidence Market by Component Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 138 Asia Pacific Real-World Evidence Market by Datasets Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 139 Asia Pacific Real-World Evidence Market by Therapeutic Area Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 140 Asia Pacific Real-World Evidence Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 141 Japan Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 142 Japan Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 143 Japan Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 144 Japan Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 145 Japan Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 146 China Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 147 China Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 148 China Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 149 China Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 150 China Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 151 India Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 152 India Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 153 India Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 154 India Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 155 India Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 156 Rest of Asia Pacific Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 157 Rest of Asia Pacific Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 158 Rest of Asia Pacific Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 159 Rest of Asia Pacific Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 160 Rest of Asia Pacific Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 161 RoW Real-World Evidence Market by Component Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 162 RoW Real-World Evidence Market by Datasets Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 163 RoW Real-World Evidence Market by Therapeutic Area Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 164 RoW Real-World Evidence Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 165 RoW Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 166 RoW Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 167 RoW Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 168 RoW Real-World Evidence Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 169 Iqvia: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 170 Iqvia: Product Portfolio
  • Table 171 IBM: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 172 IBM: Product Portfolio
  • Table 173 Pharmaceutical Product Development (PPD): Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 174 Pharmaceutical Product Development (PPD): Product Portfolio
  • Table 175 Parexel: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 176 Parexel: Product Portfolio
  • Table 177 Optum (Subsidiary of United Health Group, Inc.): Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 178 Optum (Subsidiary of United Health Group, Inc.): Product Portfolio
  • Table 179 PerkinElmer Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 180 PerkinElmer Inc.: Product Portfolio
  • Table 181 Icon PLC: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 182 Icon PLC: Product Portfolio
  • Table 183 Anthem: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 184 Anthem: Product Portfolio
  • Table 1 Oracle: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 185 Oracle: Product Portfolio
  • Table 186 Cognizant: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 187 Syneos Health: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 188 Syneos Health: Product Portfolio
  • Table 189 Clinigen: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 190 Clinigen: Product Portfolio
  • Table 191 Covance Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 192 Covance Inc.: Product Portfolio

List of Figures

  • Figure 1 Global Real-World Evidence Solutions Market: Drivers, Restraints & Opportunities
  • Figure 2 Porter's Analysis
  • Figure 3 Global Real-World Evidence Solutions Market Forecast by Component, 2020-2030 (US$ million, AGR %)
  • Figure 4 Global Real-World Evidence Solutions Market Share Forecast by Component, 2020, 2025, 2030 (%)
  • Figure 5 Global Real-World Evidence Solutions Market for Data Sets Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 6 Global Real-World Evidence Solutions Market for Data Sets Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 7 Global Real-World Evidence Solutions Market for Data Sets Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 8 Global Real-World Evidence Solutions Market for Data Sets Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 9 Global Real-World Evidence Solutions Market for Data Sets Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 10 Global Real-World Evidence Solutions Market for Services Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 11 Global Real-World Evidence Solutions Market for Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 12 Global Real-World Evidence Solutions Market for Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 13 Global Real-World Evidence Solutions Market for Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 14 Global Real-World Evidence Solutions Market for Services Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 15 Global Real-World Evidence Solutions Market Forecast by Datasets, 2020-2030 (US$ million, AGR %)
  • Figure 16 Global Real-World Evidence Solutions Market Share Forecast by Datasets, 2020, 2025, 2030 (%)
  • Figure 17 Global Real-World Evidence Solutions Market for Clinical Settings Data Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 18 Global Real-World Evidence Solutions Market for Clinical Settings Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 19 Global Real-World Evidence Solutions Market for Clinical Settings Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 20 Global Real-World Evidence Solutions Market for Clinical Settings Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 21 Global Real-World Evidence Solutions Market for Clinical Settings Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 22 Global Real-World Evidence Solutions Market for Claims Data Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 23 Global Real-World Evidence Solutions Market for Claims Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 24 Global Real-World Evidence Solutions Market for Claims Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 25 Global Real-World Evidence Solutions Market for Claims Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 26 Global Real-World Evidence Solutions Market for Claims Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 27 Global Real-World Evidence Solutions Market for Pharmacy Data Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 28 Global Real-World Evidence Solutions Market for Pharmacy Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 29 Global Real-World Evidence Solutions Market for Pharmacy Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 30 Global Real-World Evidence Solutions Market for Pharmacy Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 31 Global Real-World Evidence Solutions Market for Pharmacy Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 32 Global Real-World Evidence Solutions Market for Patient-Powered Data Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 33 Global Real-World Evidence Solutions Market for Patient-Powered Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 34 Global Real-World Evidence Solutions Market for Patient-Powered Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 35 Global Real-World Evidence Solutions Market for Patient-Powered Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 36 Global Real-World Evidence Solutions Market for Patient-Powered Data Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 37 Global Real-World Evidence Solutions Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR %)
  • Figure 38 Global Real-World Evidence Solutions Market Share Forecast by Therapeutic Area, 2020, 2025, 2030 (%)
  • Figure 39 Global Real-World Evidence Solutions Market for Oncology Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 40 Global Real-World Evidence Solutions Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 41 Global Real-World Evidence Solutions Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 42 Global Real-World Evidence Solutions Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 43 Global Real-World Evidence Solutions Market for Oncology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 44 Global Real-World Evidence Solutions Market for Cardiovascular Diseases Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 45 Global Real-World Evidence Solutions Market for Cardiovascular Diseases Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 46 Global Real-World Evidence Solutions Market for Cardiovascular Diseases Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 47 Global Real-World Evidence Solutions Market for Cardiovascular Diseases Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 48 Global Real-World Evidence Solutions Market for Cardiovascular Diseases Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 49 Global Real-World Evidence Solutions Market for Neurology Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 50 Global Real-World Evidence Solutions Market for Neurology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 51 Global Real-World Evidence Solutions Market for Neurology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 52 Global Real-World Evidence Solutions Market for Neurology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 53 Global Real-World Evidence Solutions Market for Neurology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 54 Global Real-World Evidence Solutions Market for Immunology Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 55 Global Real-World Evidence Solutions Market for Immunology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 56 Global Real-World Evidence Solutions Market for Immunology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 57 Global Real-World Evidence Solutions Market for Immunology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 58 Global Real-World Evidence Solutions Market for Immunology Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 59 Global Real-World Evidence Solutions Market for Other Therapeutic Areas Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 60 Global Real-World Evidence Solutions Market for Other Therapeutic Areas Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 61 Global Real-World Evidence Solutions Market for Other Therapeutic Areas Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 62 Global Real-World Evidence Solutions Market for Other Therapeutic Areas Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 63 Global Real-World Evidence Solutions Market for Other Therapeutic Areas Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 64 Global Real-World Evidence Solutions Market Forecast by End-Users, 2020-2030 (US$ million, AGR %)
  • Figure 65 Global Real-World Evidence Solutions Market Share Forecast by End-Users, 2020, 2025, 2030 (%)
  • Figure 66 Global Real-World Evidence Solutions Market for Healthcare Payers Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 67 Global Real-World Evidence Solutions Market for Healthcare Payers Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 68 Global Real-World Evidence Solutions Market for Healthcare Payers Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 69 Global Real-World Evidence Solutions Market for Healthcare Payers Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 70 Global Real-World Evidence Solutions Market for Healthcare Payers Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 71 Global Real-World Evidence Solutions Market for Healthcare Providers Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 72 Global Real-World Evidence Solutions Market for Healthcare Providers Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 73 Global Real-World Evidence Solutions Market for Healthcare Providers Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 74 Global Real-World Evidence Solutions Market for Healthcare Providers Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 75 Global Real-World Evidence Solutions Market for Healthcare Providers Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 76 Global Real-World Evidence Solutions Market for Pharmaceutical & Medical Device Companies Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 77 Global Real-World Evidence Solutions Market for Pharmaceutical & Medical Device Companies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 78 Global Real-World Evidence Solutions Market for Pharmaceutical & Medical Device Companies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 79 Global Real-World Evidence Solutions Market for Pharmaceutical & Medical Device Companies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 80 Global Real-World Evidence Solutions Market for Pharmaceutical & Medical Device Companies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 81 Global Real-World Evidence Solutions Market for Other End-Users Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 82 Global Real-World Evidence Solutions Market for Other End-Users Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 83 Global Real-World Evidence Solutions Market for Other End-Users Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 84 Global Real-World Evidence Solutions Market for Other End-Users Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 85 Global Real-World Evidence Solutions Market for Other End-Users Segment, Revenue Forecast 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 86 Global Real-World Evidence Solutions Market Forecast by Region 2020-2030 (US$ million)
  • Figure 87 Global Real-World Evidence Solutions Market Share Forecast by Region 2020, 2025, 2030 (%)
  • Figure 88 North America Real-World Evidence Solutions Market Forecast by Country 2020-2030 (US$ million)
  • Figure 89 North America Real-World Evidence Solutions Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 90 North America Real-World Evidence Solutions Market Forecast by Component, 2020-2030 (US$ million, AGR%)
  • Figure 91 North America Real-World Evidence Solutions Market Forecast by Datasets, 2020-2030 (US$ million, AGR%)
  • Figure 92 North America Real-World Evidence Solutions Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
  • Figure 93 North America Real-World Evidence Solutions Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
  • Figure 94 U.S. Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 95 U.S. Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 96 U.S. Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 97 U.S. Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 98 U.S. Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 99 Canada Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 100 Canada Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 101 Canada Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 102 Canada Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 103 Canada Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 104 Europe Real-World Evidence Solutions Market Forecast by Country 2020-2030 (US$ million)
  • Figure 105 Europe Real-World Evidence Solutions Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 106 Europe Real-World Evidence Solutions Market Forecast by Component, 2020-2030 (US$ million, AGR%)
  • Figure 107 Europe Real-World Evidence Solutions Market Forecast by Datasets, 2020-2030 (US$ million, AGR%)
  • Figure 108 Europe Real-World Evidence Solutions Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
  • Figure 109 Europe Real-World Evidence Solutions Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
  • Figure 110 Germany Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 111 Germany Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 112 Germany Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 113 Germany Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 114 Germany Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 115 France Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 116 France Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 117 France Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 118 France Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 119 France Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 120 UK Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 121 UK Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 122 UK Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 123 UK Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 124 UK Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 125 Italy Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 126 Italy Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 127 Italy Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 128 Italy Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 129 Italy Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 130 Spain Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 131 Spain Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 132 Spain Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 133 Spain Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 134 Spain Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 135 Rest of Europe Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 136 Rest of Europe Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 137 Rest of Europe Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 138 Rest of Europe Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 139 Rest of Europe Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 140 Asia Pacific Real-World Evidence Solutions Market Forecast by Country 2020-2030 (US$ million)
  • Figure 141 Asia Pacific Real-World Evidence Solutions Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 142 Asia Pacific Real-World Evidence Solutions Market Forecast by Component, 2020-2030 (US$ million, AGR%)
  • Figure 143 Asia Pacific Real-World Evidence Solutions Market Forecast by Datasets, 2020-2030 (US$ million, AGR%)
  • Figure 144 Asia Pacific Real-World Evidence Solutions Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
  • Figure 145 Asia Pacific Real-World Evidence Solutions Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
  • Figure 146 Japan Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 147 Japan Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 148 Japan Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 149 Japan Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 150 Japan Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 151 China Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 152 China Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 153 China Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 154 China Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 155 China Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 156 India Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 157 India Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 158 India Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 159 India Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 160 India Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 161 Rest of Asia Pacific Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 162 Rest of Asia Pacific Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 163 Rest of Asia Pacific Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 164 Rest of Asia Pacific Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 165 Rest of Asia Pacific Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 166 RoW Real-World Evidence Solutions Market Forecast by Component, 2020-2030 (US$ million, AGR%)
  • Figure 167 RoW Real-World Evidence Solutions Market Forecast by Datasets, 2020-2030 (US$ million, AGR%)
  • Figure 168 RoW Real-World Evidence Solutions Market Forecast by Therapeutic Area, 2020-2030 (US$ million, AGR%)
  • Figure 169 RoW Real-World Evidence Solutions Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
  • Figure 170 RoW Real-World Evidence Solutions Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 171 RoW Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 172 RoW Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 173 RoW Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 174 RoW Real-World Evidence Solutions Market Forecast, 2020-2030 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 175 Iqvia: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 176 Iqvia: EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 177 Iqvia: Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 178 Iqvia: Segmental Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 179 IBM: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 180 IBM: EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 181 IBM: Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 182 Optum (Subsidiary of United Health Group, Inc.): Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 183 Optum (Subsidiary of United Health Group, Inc.): EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 184 Optum (Subsidiary of United Health Group, Inc.): Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 185 PerkinElmer Inc.: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 186 PerkinElmer Inc.: EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 187 PerkinElmer Inc.: Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 188 Icon PLC: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 189 Icon PLC: EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 190 Icon PLC: Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 191 Anthem: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 192 Anthem: EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 193 Anthem: Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 194 Oracle: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 195 Oracle: EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 196 Oracle: Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 197 Cognizant: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 198 Cognizant: EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 199 Cognizant: Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 200 Syneos Health: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 201 Syneos Health: EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 202 Syneos Health: Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 203 Clinigen: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 204 Clinigen: EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 205 Clinigen: Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 206 Covance Inc.: Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 207 Covance Inc.: Gross Profit, 2015-2019 (US$ Mn, AGR%)

Companies Profiled in the Report:

  • Anthem
  • Clinigen
  • Cognizant
  • Covance Inc.
  • IBM
  • Icon PLC
  • Iqvia
  • Optum (A Subsidiary of United Health Group, Inc.)
  • Oracle
  • PAREXEL
  • PerkinElmer
  • Pharmaceutical Product Development
  • Syneos Health

List of Other Companies:

  • Evidence Based Solutions
  • Evidera
  • Fuzzy Logix
  • Genospace
  • HealThink
  • IBM Watson Health
  • Ignite Data
  • Indegene
  • Infosys
  • Ingress Health
  • InnoWin
  • Inovalon
  • Kx Systems
  • Lifecode Solutions
  • Medidata Solutions
  • Real Life Sciences
  • RealHealthData
  • Talking Medicines

List of Organizations:

  • Cambridge Healthtech Institute
  • CardioVascular Research Foundation
  • Centers for Disease Control and Prevention
  • European Medicines Agency
  • National Academies of Sciences, Engineering and Medicine
  • National Cancer Institute
  • National Institute of Mental Health
  • National Institutes of Health
  • Observational and Pragmatic Research Institute
  • Patient-Centered Outcomes Research Institute
  • Worldwide Clinical Trials